Ibaraki, Japan

Kentaro Hashimoto

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kentaro Hashimoto. Retrieved from https://idiyas.com/inventor/kentaro-hashimoto-lizxf7b5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kentaro Hashimoto: Innovator in Medicinal Chemistry

Introduction

Kentaro Hashimoto is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic potential.

Latest Patents

One of his notable patents is for a nitrogen-containing five-membered heterocyclic compound. This invention provides a compound represented by the formula (I), wherein each symbol is defined in the specification, or a salt thereof. The compound exhibits glucokinase activity and is useful as a medicament for the prophylaxis or treatment of diabetes, obesity, and related conditions. This innovation highlights his commitment to addressing critical health issues.

Career Highlights

Kentaro Hashimoto is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda emphasizes the importance of research and development in creating effective medical solutions.

Collaborations

Throughout his career, he has collaborated with notable colleagues, including Tsuneo Yasuma and Masahiro Ito. These partnerships have likely contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Kentaro Hashimoto's contributions to medicinal chemistry and his innovative patent for a nitrogen-containing compound underscore his role as a key figure in the fight against diabetes and obesity. His work continues to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…